» Authors » Auradee Punkvang

Auradee Punkvang

Explore the profile of Auradee Punkvang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 59
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sukchit D, Prajuabsuk M, Lumlong S, Inntam C, Punkvang A, Wattanarach S, et al.
ACS Omega . 2025 Feb; 10(6):5981-5992. PMID: 39989767
According to the large amount of fly ash waste generated from the use of lignite coal as the primary fuel for electricity generation in the Mae Moh district of Lampang...
2.
Taveepanich S, Chayajarus K, Jittimanee J, Phusri N, Thongdee P, Sawatdee K, et al.
Heliyon . 2024 Oct; 10(19):e38213. PMID: 39397930
Background: Iron overload and inflammation are severe conditions that can lead to various chronic diseases. However, the current iron chelator drugs have their limitations. The phytochemical compounds from herbals, such...
3.
Pakamwong B, Thongdee P, Kamsri B, Phusi N, Taveepanich S, Chayajarus K, et al.
J Chem Inf Model . 2024 Jul; 64(15):5991-6002. PMID: 38993154
is the single most important global infectious disease killer and a World Health Organization critical priority pathogen for development of new antimicrobials. DNA gyrase is a validated target for anti-TB...
4.
Kamsri B, Kamsri P, Punkvang A, Chimprasit A, Saparpakorn P, Hannongbua S, et al.
Biochemistry . 2024 May; 63(11):1493-1504. PMID: 38742407
DNA gyrases catalyze negative supercoiling of DNA, are essential for bacterial DNA replication, transcription, and recombination, and are important antibacterial targets in multiple pathogens, including , which in 2021 caused...
5.
Sukadeetad K, Sripanidkulchai B, Tangsukworakhun S, Payomchuen R, Sakulchatrungroj A, Supmoon S, et al.
J Ethnopharmacol . 2024 Mar; 327:118042. PMID: 38493907
Ethnopharmacological Relevance: The cluster of differentiation 147 (CD147) is identified as the signaling protein relevant importantly in various cancers, inflammations, and coronavirus disease 2019 (COVID-19) via interacting with extracellular cyclophilin...
6.
Thongdee P, Nagura Y, Sabishiro H, Phusi N, Sukchit D, Kamsri P, et al.
J Biomol Struct Dyn . 2023 Dec; 43(3):1192-1205. PMID: 38063158
Tuberculosis (TB), the second leading infectious killer, causes serious public health problems worldwide. To develop novel anti-TB agents, many biochemical studies have targeted the subunit B of DNA gyrase (GyrB),...
7.
Pornprom T, Phusi N, Thongdee P, Pakamwong B, Sangswan J, Kamsri P, et al.
Talanta . 2023 Sep; 267:125210. PMID: 37717539
Tuberculosis (TB) currently remains a major life-threatening disease as it can be fatal if not treated properly or in a timely manner. Herein, we first describe a disposable and cost-effective...
8.
Kamsri B, Pakamwong B, Thongdee P, Phusi N, Kamsri P, Punkvang A, et al.
J Chem Inf Model . 2023 Apr; 63(9):2707-2718. PMID: 37074047
Mutations in DNA gyrase confer resistance to fluoroquinolones, second-line antibiotics for infections. Identification of new agents that inhibit DNA gyrase ATPase activity is one strategy to overcome this. Here, bioisosteric...
9.
Phusi N, Hashimoto Y, Otsubo N, Imai K, Thongdee P, Sukchit D, et al.
Comput Biol Med . 2022 Dec; 152:106434. PMID: 36543008
2-trans enoyl-acyl carrier protein reductase (InhA) is a promising target for developing novel chemotherapy agents for tuberculosis, and their inhibitory effects on InhA activity were widely investigated by the physicochemical...
10.
Kamsri P, Punkvang A, Taveepanich S, Ketrat S, Saparpakorn P, Hannongbua S, et al.
Future Med Chem . 2022 Aug; 14(18):1297-1308. PMID: 36043391
JAK2 inhibitors have been proposed as a new therapeutic option for thalassemia therapy. The objective of this study was to discover the key structural features for improving 2-aminopyrimidine derivatives as...